Pimicotinib

Overview

Pimicotinib (ABSK021) is a selective and orally active CSF1R inhibitor with an IC 50 value of 19.48 nM (determined by inhibiting ADP production). Pimicotinib exhibits anti-tumor activity.

Application

Products | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Liver Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > c-Fms | Products > Signaling Pathways > c-Kit | Products > Signaling Pathways > PDGFR

Product Information

• Catalog No.: HY-153920
• CAS No.: 2253123-16-7
• Molecular Formula: C22H24N6O3
• Molecular Weight: 420.46
• Purity: 99.92%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (5.95 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source